Literature DB >> 31158351

Acute Type A Dissection Repair by High-Volume Vs Low-Volume Surgeons at a High-Volume Aortic Center.

Juan B Umana-Pizano1, Alexander P Nissen2, Harleen K Sandhu1, Charles C Miller1, Andrei Loghin1, Hazim J Safi1, Steven B Eisenberg1, Anthony L Estrera1, Tom C Nguyen3.   

Abstract

BACKGROUND: Previous studies suggest improved outcomes for acute type A dissections (ATAAD) treated at high-volume centers. It is unclear if outcomes are a result of individual surgeon experience or inherent resources available at high-volume centers. To explore this question, we stratified outcomes for ATAAD repair by low-volume and high-volume surgeons at a high-volume center.
METHODS: We reviewed our institutional experience with ATAAD between 1999 and 2016 (n = 580). To evaluate surgeon experience with ATAAD repair, we categorized surgeons as high-volume aortic surgeons (HVASs) (> 10 cases/year) or low-volume aortic surgeons (LVASs) (≤ 10 cases/year). Analysis was stratified according to the following: HVAS in primary and first assist roles, HVAS as primary with LVAS as first assist, LVAS as primary and HVAS as first assist, and LVAS in both roles.
RESULTS: The total experience for HVAS and LVAS as primary surgeon for the study period was 513 and 67, respectively. Mean annual experience as primary surgeon was 15.2 cases for HVAS and 3.4 cases for LVAS. In-hospital mortality was 14.0% if an HVAS was present and 24.0% with an all-LVAS team (P = .27). After adjusting for preoperative factors, the mortality odds ratio (OR) for an all-LVAS team was 3.72 (P = .01).
CONCLUSIONS: ATAAD repair by an all-LVAS team had nearly a 4-fold increase in-hospital mortality compared with an all-HVAS team. Improved outcomes at high-volume centers may be predominantly due to surgeon experience and not from center-specific resources. This study may have implications on call coverage for ATAAD repair at high-volume centers.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2019        PMID: 31158351     DOI: 10.1016/j.athoracsur.2019.04.040

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Is total arch replacement associated with an increased risk after acute type A dissection?

Authors:  Mohamed Salem; Christine Friedrich; Rene Rusch; Derk Frank; Grischa Hoffmann; Georg Lutter; Rouven Berndt; Jochen Cremer; Assad Haneya; Thomas Puehler
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

2.  Decode a ticking time-bomb.

Authors:  Song Wan; Jun Liu
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

3.  Association between the frequency of surgeries for video-assisted thoracic surgery and the incidence of consequent surgical site infections: a retrospective observational study based on national surveillance data.

Authors:  Toshiki Kajihara; Koji Yahara; Aki Hirabayashi; Hitomi Kurosu; Motoyuki Sugai; Keigo Shibayama
Journal:  BMC Infect Dis       Date:  2021-04-17       Impact factor: 3.090

4.  Outcomes of acute type A aortic dissection operations performed by early-career cardiovascular surgeons.

Authors:  Ting-Wei Lin; Meng-Ta Tsai; Hsuan-Yin Wu; Yi-Chen Wang; Yu-Ning Hu; Chung-Dann Kan; Jun-Neng Roan; Chwan-Yau Luo
Journal:  JTCVS Open       Date:  2021-03-18

5.  At the Crossroads of Minimally Invasive Mitral Valve Surgery-Benching Single Hospital Experience to a National Registry: A Plea for Risk Management Technology.

Authors:  Riccardo Cocchieri; Bertus van de Wetering; Sjoerd van Tuijl; Iman Mousavi; Robert Riezebos; Bastian de Mol
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-11

6.  The Many Care Models to Treat Thoracic Aortic Disease in Canada: A Nationwide Survey of Cardiac Surgeons, Cardiologists, Interventional Radiologists, and Vascular Surgeons.

Authors:  R Scott McClure; Robert F Berry; Francois Dagenais; Thomas L Forbes; Jasmine Grewal; Michelle Keir; Darren Klass; Vamshi K Kotha; M Sean McMurtry; Randy D Moore; Darrin Payne; Kenton Rommens
Journal:  CJC Open       Date:  2021-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.